These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 13560808)
41. The neutralization of cholinesterase inhibition by various oximes and by atropine. HUNTER WS; McCULLOCH C Am J Ophthalmol; 1961 Nov; 52():841-4. PubMed ID: 14450082 [No Abstract] [Full Text] [Related]
42. Blood cholinesterase activity; practical considerations in routine testing programs. WOLFSIE JH AMA Arch Ind Health; 1957 Nov; 16(5):403-10. PubMed ID: 13468806 [No Abstract] [Full Text] [Related]
43. Metabolic and acid-base changes following acute cholinesterase inhibition. GOLD AJ; WELLER JM; FREEMAN G Am J Physiol; 1957 Feb; 188(2):321-6. PubMed ID: 13411209 [No Abstract] [Full Text] [Related]
44. MALATHION POISONING WITH SPECIAL REFERENCE TO THE EFFECT OF CHOLINESTERASE INHIBITION ON ERYTHROCYTE SURVIVAL. GOLDIN AR; RUBENSTEIN AH; BRADLOW BA; ELLIOTT GA N Engl J Med; 1964 Dec; 271():1289-93. PubMed ID: 14214635 [No Abstract] [Full Text] [Related]
45. Adjunctive value of oral prophylaxis with the oximes 2-PAM lactate and 2-PAM methanesulfonate to therapeutic administration of atropine in dogs poisoned by inhaled Sarin vapor. CROOK JW; GOODMAN AI; COLBOURN JL; ZVIRBLIS P; OBERST FW; WILLS JH J Pharmacol Exp Ther; 1962 Jun; 136():397-9. PubMed ID: 13882343 [No Abstract] [Full Text] [Related]
46. The effectiveness of 2-PAM and TMB-4 as adjuncts to atropine therapy in dogs exposed to Sarin vapor by inhalation. OBERST FW; CROOK JW; KOON WS J Pharmacol Exp Ther; 1962 Jun; 136():393-6. PubMed ID: 14480993 [No Abstract] [Full Text] [Related]
47. ANTICHOLINESTERASE POISONING IN A GROUP OF DOGS. EYRE P; MACKENZIE CP Vet Rec; 1965 Mar; 77():367-8. PubMed ID: 14320640 [No Abstract] [Full Text] [Related]
50. Toxic substances and the nervous system. Barnes JM Sci Basis Med Annu Rev; 1969; ():183-201. PubMed ID: 4989832 [No Abstract] [Full Text] [Related]
51. Nikethamide, nocotinamide and some related compounds in anticholinesterase poisoning. ROSENBERG P; COON JM J Pharmacol Exp Ther; 1960 Mar; 128():289-98. PubMed ID: 14438961 [No Abstract] [Full Text] [Related]
52. 2 PAM clinical research as therapy for parathion poisoning. WILLIAMS DC New Physician; 1962 Jun; 11():182-7. PubMed ID: 14040269 [No Abstract] [Full Text] [Related]
53. Poisoning by organic phosphate insecticides. SMITH RC; KIMURA M; IBSEN M Calif Med; 1955 Sep; 83(3):240-3. PubMed ID: 13250430 [No Abstract] [Full Text] [Related]
54. Treatment of severe parathion poisoning with 2-pyridine aldoxine methiodide (2-PAM); report of a case. FUNCKES AJ Arch Environ Health; 1960 Nov; 1():404-6. PubMed ID: 13702615 [No Abstract] [Full Text] [Related]
55. A specific antidote against lethal alkyl phosphate intoxication. II. Antidotal properties. KEWITZ H; NACHMANSOHN D; WILSON IB Arch Biochem Biophys; 1956 Oct; 64(2):456-65. PubMed ID: 13363452 [No Abstract] [Full Text] [Related]
56. Studies on a group of oximes as therapeutic compounds in sarin poisoning. DULTZ L; EPSTEIN MA; FREEMAN G; GRAY EH; WEIL WB J Pharmacol Exp Ther; 1957 Apr; 119(4):522-31. PubMed ID: 13429460 [No Abstract] [Full Text] [Related]
57. A specific antidote against lethal alkyl phosphate intoxication. III. Repair of chemical lesion. KEWITZ H Arch Biochem Biophys; 1957 Feb; 66(2):263-70. PubMed ID: 13403672 [No Abstract] [Full Text] [Related]